Chuan-Ming Xie (Chuanming Xie)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Experimental & molecular medicine

Military Medical Research

Journal of investigative surgery : the official journal of the Academy of Surgical Research

Autophagy

Southwest Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Southwest Hospital Sep 01 2016

China

Professor :: Institute of Hepatobiliary Surgery

Publications

Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine 56 (1) (2024)
Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine (2024)
Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine 56 (1) (2024)
Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine 56 (1) (2024)
Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine 56 (1) (2024)
Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine 56 (1) (2024)
Xun Li, Cheng-Cheng Zhang, Xiao-Tong Lin, Jie Zhang, Yu-Jun Zhang, Hong-Qiang Yu, Ze-Yu Liu, Yi Gong, Lei-Da Zhang, Chuan-Ming Xie
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & molecular medicine 56 (1) (2024)
Hao-Jun Xiong, Hong-Qiang Yu, Jie Zhang, Lei Fang, Di Wu, Xiao-Tong Lin, Chuan-Ming Xie
Elevated FBXL6 activates both wild-type KRAS and mutant KRAS G12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice. Military Medical Research 10 (1) (2023)
Hao-Jun Xiong, Hong-Qiang Yu, Jie Zhang, Lei Fang, Di Wu, Xiao-Tong Lin, Chuan-Ming Xie
Elevated FBXL6 activates both wild-type KRAS and mutant KRAS G12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice. Military Medical Research 10 (1) (2023)
Hao-Jun Xiong, Hong-Qiang Yu, Jie Zhang, Lei Fang, Di Wu, Xiao-Tong Lin, Chuan-Ming Xie
Elevated FBXL6 activates both wild-type KRAS and mutant KRAS G12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice. Military Medical Research 10 (1) (2023)
Jie Zhang, Xiao-Tong Lin, Hong-Qiang Yu, Lei Fang, Di Wu, Yuan-Deng Luo, Yu-Jun Zhang, Chuan-Ming Xie
Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. Experimental & molecular medicine (2023)
Jie Zhang, Xiao-Tong Lin, Hong-Qiang Yu, Lei Fang, Di Wu, Yuan-Deng Luo, Yu-Jun Zhang, Chuan-Ming Xie
Author Correction: Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. Experimental & molecular medicine (2023)
Hao-Jun Xiong, Hong-Qiang Yu, Jie Zhang, Lei Fang, Di Wu, Xiao-Tong Lin, Chuan-Ming Xie
Elevated FBXL6 activates both wild-type KRAS and mutant KRAS G12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice. Military Medical Research 10 (1) (2023)
Ye Tan, Di Wu, Ze-Yu Liu, Hong-Qiang Yu, Xiang-Ru Zheng, Xiao-Tong Lin, Ping Bie, Lei- Da Zhang, Chuan-Ming Xie
Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis. Journal of molecular cell biology (2023)
Hao-Jun Xiong, Hong-Qiang Yu, Jie Zhang, Lei Fang, Di Wu, Xiao-Tong Lin, Chuan-Ming Xie
Elevated FBXL6 activates both wild-type KRAS and mutant KRAS G12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice. Military Medical Research 10 (1) (2023)
Xiao-Tong Lin, Hong-Qiang Yu, Lei Fang, Ye Tan, Ze-Yu Liu, Di Wu, Jie Zhang, Hao-Jun Xiong, Chuan-Ming Xie
Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation. eLife 10 (2021)
Yuan-Deng Luo, Hong-Qiang Yu, Xiao-Yu Liu, Deng Huang, Hai-Su Dai, Lei Fang, Yu-Jun Zhang, Jie-Juan Lai, Yan Jiang, Ling Shuai, Lei-Da Zhang, Geng Chen, Ping Bie, Chuan-Ming Xie
Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma. Cancer medicine 9 (12) (2020)
Chuan-Ming Xie, Yi Sun
The MTORC1-mediated autophagy is regulated by the FBXW7-SHOC2-RPTOR axis. Autophagy 15 (8) (2019)
Yan Chen, Peng Jiang, Feng Tian, Guangyu Chen, Tao Peng, Xiaoming Deng, Zhonghu Li, Den Huang, Jin Zhu, Ping Zhen, Chuan-Ming Xie, Shuguang Wang
Effects of Y Box Binding Protein-1 in Progression and Prognosis of Cholangiocarcinoma. Journal of investigative surgery : the official journal of the Academy of Surgical Research 34 (1) (2019)

Chuan-Ming Xie.css-eqlu8i{font-size:small;padding-left:4px;} (Chuanming Xie)

Publication Activity (10 Years)

Top Topics

Top Venues

Chuan-Ming Xie (Chuanming Xie)